Challenges of general safety evaluations of biologics compared to small molecule pharmaceuticals in animal models

By Dixit Rakesh   Iciek Laurie A   McKeever Kathleen   Ryan Patricia Clare  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 79-94

Informa Healthcare

Access to resources Recommend Favorite

Haemozoin Formation as a Target for the Rational Design of New Antimalarials

By  

Drug Design Reviews - Online, Vol. 1, Iss. 1, 2004-01 ,pp. : 93-110

Bentham Science Publishers

Access to resources Recommend Favorite

Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation

By Höfer Thomas  

Archives of Toxicology, Vol. 78, Iss. 10, 2004-10 ,pp. : 549-564

Springer Publishing Company

Access to resources Recommend Favorite

Assessing the Absorption of New Pharmaceuticals

By  

Current Topics in Medicinal Chemistry, Vol. 1, Iss. 5, 2001-11 ,pp. : 385-401

Bentham Science Publishers

Access to resources Recommend Favorite

Basis for a Proposed Reference Dose (RfD) for Dioxin of 1-10 PG/KG-Day: A Weight of Evidence Evaluation of the Human and Animal Studies

By Greene Jessica   Hays Sean   Paustenbach Dennis  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 6, Iss. 2, 2003-01 ,pp. : 115-159

Taylor & Francis Ltd

Access to resources Recommend Favorite